EWCZ Quote, Financials, Valuation and Earnings

Hims & Hers Health has a net margin of 3.37% compared to European Wax Center's net margin of 8.44%. European Wax Center's return on equity of 9.03% beat Hims & Hers Health's return on equity of 37.84%.

European Wax Center has a consensus price target of $6.71, signalling upside risk potential of 16.97%. On the other hand Hims & Hers Health has an analysts' consensus of $49.80 which suggests that it could fall by -10.25%. Given that European Wax Center has higher upside potential than Hims & Hers Health, analysts believe European Wax Center is more attractive than Hims & Hers Health.

European Wax Center has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 2.094, suggesting its more volatile than the S&P 500 by 109.43%.

European Wax Center has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. European Wax Center pays 7.54% of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

European Wax Center quarterly revenues are $51.4M, which are smaller than Hims & Hers Health quarterly revenues of $586M. European Wax Center's net income of $1.7M is lower than Hims & Hers Health's net income of $49.5M. Notably, European Wax Center's price-to-earnings ratio is 28.14x while Hims & Hers Health's PE ratio is 80.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for European Wax Center is 1.21x versus 7.50x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.

Kenvue has a net margin of 3.37% compared to European Wax Center's net margin of 8.61%. European Wax Center's return on equity of 9.03% beat Kenvue's return on equity of 10.32%.

European Wax Center has a consensus price target of $6.71, signalling upside risk potential of 16.97%. On the other hand Kenvue has an analysts' consensus of $24.54 which suggests that it could grow by 14.39%. Given that European Wax Center has higher upside potential than Kenvue, analysts believe European Wax Center is more attractive than Kenvue.

European Wax Center has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

European Wax Center has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue offers a yield of 3.82% to investors and pays a quarterly dividend of $0.21 per share. European Wax Center pays 7.54% of its earnings as a dividend. Kenvue pays out 150.68% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Kenvue's is not.

European Wax Center quarterly revenues are $51.4M, which are smaller than Kenvue quarterly revenues of $3.7B. European Wax Center's net income of $1.7M is lower than Kenvue's net income of $322M. Notably, European Wax Center's price-to-earnings ratio is 28.14x while Kenvue's PE ratio is 39.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for European Wax Center is 1.21x versus 2.70x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health has a net margin of 3.37% compared to European Wax Center's net margin of -14.51%. European Wax Center's return on equity of 9.03% beat The Beauty Health's return on equity of -66.39%.

European Wax Center has a consensus price target of $6.71, signalling upside risk potential of 16.97%. On the other hand The Beauty Health has an analysts' consensus of $1.76 which suggests that it could grow by 15.03%. Given that European Wax Center has higher upside potential than The Beauty Health, analysts believe European Wax Center is more attractive than The Beauty Health.

European Wax Center has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

European Wax Center has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. European Wax Center pays 7.54% of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

European Wax Center quarterly revenues are $51.4M, which are smaller than The Beauty Health quarterly revenues of $69.6M. European Wax Center's net income of $1.7M is higher than The Beauty Health's net income of -$10.1M. Notably, European Wax Center's price-to-earnings ratio is 28.14x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for European Wax Center is 1.21x versus 0.63x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.